Search
Veradermics, a company trying to change hair loss, so far has been one of the best performing IPOs in biotech in many years
CEO Reid Waldman walks us through the company's treatment, VDPHL01, which is an extended-release oral formulation of minoxidil, and he sets the table for three key readouts the company has coming up. Plus, the company's regulatory strategy and how he sees the commercial market.
1 day ago
.png){kind=logo}